Trending

Chi-Med

Chi-Med agrees R&D partnership with Inmagene

Chi-Med agrees R&D partnership with Inmagene

China’s Chi-Med and Inmagene Biopharmaceuticals have agreed a strategic partnership to develop preclinical drug candidates for potential treatment

X

Chi-Med agrees R&D partnership with Inmagene

https://pharmaphorum.com/news/chi-med-agrees-rd-partnership-with-inmagene/

AstraZeneca files Imfinzi for groundbreaking lung cancer use

AstraZeneca files Imfinzi for groundbreaking lung cancer use

AZ also unveils promising results from early-stage lung cancer combination

X

AstraZeneca files Imfinzi for groundbreaking lung cancer use

https://pharmaphorum.com/news/az-files-for-us-early-lung-cancer-licence-for-imfinzi/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com